Javascript must be enabled to continue!
An Ancestral Trk Receptor
View through CrossRef
No true invertebrate homologs of the vertebrate neurotrophin Trk receptors have been identified in the genomes of the model organisms
Drosophila melanogaster
and
Caenorhabditis elegans
, which has led to the hypothesis that the Trk signaling arose in vertebrates. Benito-Gutiérrez
et al.
challenge this hypothesis with the identification of a Trk receptor in the genome of the lancelet
Branchiostoma floridae
, which is the present-day relative of the lancelet-like organism believed to be the ancestor of vertebrates. Lancelets are invertebrate fish-like animals that lack a complex nervous system. They have named the lancelet gene
AmphiTrk
, and the encoded protein has the same domain structure as vertebrate Trk receptors: The extracellular region contained two leucine-rich repeats flanked by cysteine-rich clusters and followed by two C2-type immunoglobulin repeats, and the intracellular domain included a tyrosine kinase domain, two putative cyclic nucleotide-dependent kinase phosphorylation sites, and various protein-protein interaction motifs also found in vertebrate Trk receptors. Thus, the ligand-binding domain and the intracellular signaling regions of AmphiTrk are consistent with this receptor's being an invertebrate homolog of Trk. Phylogenetic analysis showed that AmphiTrk formed a clade (an evolutionarily related group) with the vertebrate Trk receptors that excluded the two closest relatives from fruit fly and mollusk. Transfection of AmphiTrk into a Trk-negative PC12 cell line showed that AmphiTrk was stimulated by several neurotrophins (NGF, NT3, NT4, and BDNF). The cellular response was not completely identical to that of native receptors in that AmphiTrk did not stimulate phospholipase C activity (which is consistent with the sequence of AmphiTrk lacking the necessary motif) and exposure of the cells expressing AmphiTrk to NGF did not further stimulate neurite outgrowth beyond that observed in the absence of ligand. (AmphiTrk in the absence of ligand did stimulate neurite outgrowth.) Analysis of the expression of
AmphiTrk
in vivo during development suggested that AmphiTrk was present in migrating sensory neurons. Thus, AmphiTrk appears to represent a true invertebrate member of the Trk receptor family with functional and sequence homology.
È. Benito-Gutiérrez, C. Nake, M. Llovera, J. X. Comella, J. Garcia-Fernàndez, The single AmphiTrk receptor highlights increased complexity of neurotrophin signalling in vertebrates and suggests an early role in developing sensory neuroepidermal cells.
Development
132
, 2191-2202 (2005).
[Abstract]
[Full Text]
Title: An Ancestral Trk Receptor
Description:
No true invertebrate homologs of the vertebrate neurotrophin Trk receptors have been identified in the genomes of the model organisms
Drosophila melanogaster
and
Caenorhabditis elegans
, which has led to the hypothesis that the Trk signaling arose in vertebrates.
Benito-Gutiérrez
et al.
challenge this hypothesis with the identification of a Trk receptor in the genome of the lancelet
Branchiostoma floridae
, which is the present-day relative of the lancelet-like organism believed to be the ancestor of vertebrates.
Lancelets are invertebrate fish-like animals that lack a complex nervous system.
They have named the lancelet gene
AmphiTrk
, and the encoded protein has the same domain structure as vertebrate Trk receptors: The extracellular region contained two leucine-rich repeats flanked by cysteine-rich clusters and followed by two C2-type immunoglobulin repeats, and the intracellular domain included a tyrosine kinase domain, two putative cyclic nucleotide-dependent kinase phosphorylation sites, and various protein-protein interaction motifs also found in vertebrate Trk receptors.
Thus, the ligand-binding domain and the intracellular signaling regions of AmphiTrk are consistent with this receptor's being an invertebrate homolog of Trk.
Phylogenetic analysis showed that AmphiTrk formed a clade (an evolutionarily related group) with the vertebrate Trk receptors that excluded the two closest relatives from fruit fly and mollusk.
Transfection of AmphiTrk into a Trk-negative PC12 cell line showed that AmphiTrk was stimulated by several neurotrophins (NGF, NT3, NT4, and BDNF).
The cellular response was not completely identical to that of native receptors in that AmphiTrk did not stimulate phospholipase C activity (which is consistent with the sequence of AmphiTrk lacking the necessary motif) and exposure of the cells expressing AmphiTrk to NGF did not further stimulate neurite outgrowth beyond that observed in the absence of ligand.
(AmphiTrk in the absence of ligand did stimulate neurite outgrowth.
) Analysis of the expression of
AmphiTrk
in vivo during development suggested that AmphiTrk was present in migrating sensory neurons.
Thus, AmphiTrk appears to represent a true invertebrate member of the Trk receptor family with functional and sequence homology.
È.
Benito-Gutiérrez, C.
Nake, M.
Llovera, J.
X.
Comella, J.
Garcia-Fernàndez, The single AmphiTrk receptor highlights increased complexity of neurotrophin signalling in vertebrates and suggests an early role in developing sensory neuroepidermal cells.
Development
132
, 2191-2202 (2005).
[Abstract]
[Full Text].
Related Results
Alterations in Trk A, Trk B and Trk C Receptor Immunoreactivities in Parietal Cortex and Cerebellum in Alzheimer’s Disease
Alterations in Trk A, Trk B and Trk C Receptor Immunoreactivities in Parietal Cortex and Cerebellum in Alzheimer’s Disease
The neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 bind to the tyrosine kinase (trk) receptors trk A, trk B and trk C, respectively, with h...
Abstract 2954A: A potent and selective TRK inhibitor ONO-5390556, shows potent antitumor activity against both TRK-rearranged cancers and the resistant mutants
Abstract 2954A: A potent and selective TRK inhibitor ONO-5390556, shows potent antitumor activity against both TRK-rearranged cancers and the resistant mutants
Abstract
Purpose: TRKA/NTRK1, TRKB/NTRK2 and TRKC/NTRK3 belong to the neurotrophic tyrosine kinase receptor family and signals from TRK receptors play a role in neur...
Abstract C65: TRK kinase domain mutations that induce resistance to a pan-TRK inhibitor
Abstract C65: TRK kinase domain mutations that induce resistance to a pan-TRK inhibitor
Abstract
Background: Gene fusions involving members of the NTRK family have been identified in several types of cancer. The use of TRK inhibitors in vitro and in viv...
Signal Transduction Pathways through TRK‐A and TRK‐B Receptors in Human Neuroblastoma Cells
Signal Transduction Pathways through TRK‐A and TRK‐B Receptors in Human Neuroblastoma Cells
Little is known about the signal transduction pathways of TRK family receptors in neuroblastoma (NB) cells. In this study, an NB cell line, designated MP‐N‐TS, was established from...
Data from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
Data from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
<div>Abstract<p>Members of the tropomyosin receptor kinase (TRK) family are expressed in their constitutively activated forms as a result of a gene fusion that occurs a...
Data from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
Data from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
<div>Abstract<p>Members of the tropomyosin receptor kinase (TRK) family are expressed in their constitutively activated forms as a result of a gene fusion that occurs a...
TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs
TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs
Recently, two tropomycin receptor kinase (Trk) inhibitors, larotrectinib and entrectinib, have been approved for Trk fusion-positive cancer patients. Clinical trials for larotrecti...
TRK expressions and NTRK rearrangements in Pediatric Tumors
TRK expressions and NTRK rearrangements in Pediatric Tumors
Abstract
Background:
Neurotrophic tyrosine receptor kinase (NTRK) genes that include NTRK1, NTRK2, NTRK3 and express TRKA, TRKB, TRKC proteins, respectively, are oncogenic ...

